FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283516103> ?p ?o ?g. }

• W4283516103 endingPage "3138" @default.
• W4283516103 startingPage "3124" @default.
• W4283516103 abstract "Abstract Aims Clinical data on the prognostic determinants over varying periods within the same cohort of heart failure with mid‐range or mildly reduced ejection fraction (HFmrEF) remain scarce. This study aimed to identify the short‐term, intermediate‐term, and long‐term risk factors of adverse cardiovascular (CV) outcomes in patients hospitalized for HFmrEF. Methods and results This retrospective study included 1691 consecutive HFmrEF patients admitted to our hospital between January 2015 and August 2020. Baseline data including clinical characteristics, laboratory and cardiac imaging examinations were obtained. Patients completed at least 1 year clinical follow‐up after discharge by telephone interview, clinical visit, or community visit. The primary endpoint was defined as a composite of CV death or rehospitalization for heart failure (CV events) at 3, 12, and 33 months after the diagnosis of HFmrEF. Mean age of the whole cohort was 69 (61–77) years and 64.8% were male. The median clinical follow‐up was 33 (20–50) months. CV events were 17.5%, 28.2%, and 57.8% at 3, 12, and 33 months after discharge, respectively. Independent risk factors for CV events were uric acid >382 μmol/L, creatinine >100 μmol/L, N‐terminal pro‐B type natriuretic peptide (NT‐proBNP) > 3368 pg/mL and haemoglobin <120 g/L for men and <110 g/L for women at 3 and 12 months. Pulmonary artery systolic pressure >35 mmHg and the ratio of early transmitral flow velocity to early mitral annular velocity >18 served as independent risk factors for CV events at 12 months. At 33 months, uric acid > 382 μmol/L, NT‐proBNP >3368 pg/mL, and pulmonary artery systolic pressure >35 mmHg were the independent risk factors of CV events. Conclusions Higher uric acid, creatinine, NT‐proBNP, and lower haemoglobin levels at baseline are valuable serum biomarkers for risk stratification of short‐term and long‐term CV outcomes of HFmrEF patients. Future studies are needed to verify if intensive heart failure therapy for identified high‐risk HFmrEF patients based on these four serum biomarkers could improve their short‐term and long‐term CV outcomes or not." @default.
• W4283516103 created "2022-06-27" @default.
• W4283516103 creator A5001360830 @default.
• W4283516103 creator A5007498494 @default.
• W4283516103 creator A5013517277 @default.
• W4283516103 creator A5015005170 @default.
• W4283516103 creator A5016664111 @default.
• W4283516103 creator A5024448885 @default.
• W4283516103 creator A5049615315 @default.
• W4283516103 creator A5061389636 @default.
• W4283516103 creator A5062081392 @default.
• W4283516103 creator A5065704886 @default.
• W4283516103 creator A5076444339 @default.
• W4283516103 creator A5083230906 @default.
• W4283516103 creator A5083834597 @default.
• W4283516103 creator A5088439848 @default.
• W4283516103 creator A5090226018 @default.
• W4283516103 date "2022-06-25" @default.
• W4283516103 modified "2023-10-16" @default.
• W4283516103 title "Risk factors of short‐term, intermediate‐term, and long‐term cardiac events in patients hospitalized for HFmrEF" @default.
• W4283516103 cites W1548051344 @default.
• W4283516103 cites W1553109049 @default.
• W4283516103 cites W1900173585 @default.
• W4283516103 cites W1992235259 @default.
• W4283516103 cites W2054600408 @default.
• W4283516103 cites W2094741808 @default.
• W4283516103 cites W2099156846 @default.
• W4283516103 cites W2148910374 @default.
• W4283516103 cites W2216822307 @default.
• W4283516103 cites W2291286562 @default.
• W4283516103 cites W2427094903 @default.
• W4283516103 cites W2475261460 @default.
• W4283516103 cites W2600206260 @default.
• W4283516103 cites W2771310329 @default.
• W4283516103 cites W2776816750 @default.
• W4283516103 cites W2785790358 @default.
• W4283516103 cites W2790189896 @default.
• W4283516103 cites W2790210259 @default.
• W4283516103 cites W2790582449 @default.
• W4283516103 cites W2809850559 @default.
• W4283516103 cites W2900192457 @default.
• W4283516103 cites W2945947019 @default.
• W4283516103 cites W2970528453 @default.
• W4283516103 cites W3024452331 @default.
• W4283516103 cites W3110449665 @default.
• W4283516103 cites W3157562486 @default.
• W4283516103 cites W3159911342 @default.
• W4283516103 cites W3165106701 @default.
• W4283516103 cites W3183298585 @default.
• W4283516103 cites W3193598686 @default.
• W4283516103 cites W3198628337 @default.
• W4283516103 cites W4283516103 @default.
• W4283516103 cites W4293860347 @default.
• W4283516103 doi "https://doi.org/10.1002/ehf2.14044" @default.
• W4283516103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35751458" @default.
• W4283516103 hasPublicationYear "2022" @default.
• W4283516103 type Work @default.
• W4283516103 citedByCount "3" @default.
• W4283516103 countsByYear W42835161032022 @default.
• W4283516103 countsByYear W42835161032023 @default.
• W4283516103 crossrefType "journal-article" @default.
• W4283516103 hasAuthorship W4283516103A5001360830 @default.
• W4283516103 hasAuthorship W4283516103A5007498494 @default.
• W4283516103 hasAuthorship W4283516103A5013517277 @default.
• W4283516103 hasAuthorship W4283516103A5015005170 @default.
• W4283516103 hasAuthorship W4283516103A5016664111 @default.
• W4283516103 hasAuthorship W4283516103A5024448885 @default.
• W4283516103 hasAuthorship W4283516103A5049615315 @default.
• W4283516103 hasAuthorship W4283516103A5061389636 @default.
• W4283516103 hasAuthorship W4283516103A5062081392 @default.
• W4283516103 hasAuthorship W4283516103A5065704886 @default.
• W4283516103 hasAuthorship W4283516103A5076444339 @default.
• W4283516103 hasAuthorship W4283516103A5083230906 @default.
• W4283516103 hasAuthorship W4283516103A5083834597 @default.
• W4283516103 hasAuthorship W4283516103A5088439848 @default.
• W4283516103 hasAuthorship W4283516103A5090226018 @default.
• W4283516103 hasBestOaLocation W42835161031 @default.
• W4283516103 hasConcept C126322002 @default.
• W4283516103 hasConcept C164705383 @default.
• W4283516103 hasConcept C167135981 @default.
• W4283516103 hasConcept C203092338 @default.
• W4283516103 hasConcept C2775915353 @default.
• W4283516103 hasConcept C2778198053 @default.
• W4283516103 hasConcept C2780306776 @default.
• W4283516103 hasConcept C535046627 @default.
• W4283516103 hasConcept C71924100 @default.
• W4283516103 hasConcept C72563966 @default.
• W4283516103 hasConcept C78085059 @default.
• W4283516103 hasConceptScore W4283516103C126322002 @default.
• W4283516103 hasConceptScore W4283516103C164705383 @default.
• W4283516103 hasConceptScore W4283516103C167135981 @default.
• W4283516103 hasConceptScore W4283516103C203092338 @default.
• W4283516103 hasConceptScore W4283516103C2775915353 @default.
• W4283516103 hasConceptScore W4283516103C2778198053 @default.
• W4283516103 hasConceptScore W4283516103C2780306776 @default.
• W4283516103 hasConceptScore W4283516103C535046627 @default.
• W4283516103 hasConceptScore W4283516103C71924100 @default.
• W4283516103 hasConceptScore W4283516103C72563966 @default.

• next